About Emmanuelle Charpentier
Emmanuelle Charpentier is considered a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial pathogens.
She is Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin, an institute that she founded together with the Max Planck Society. She is also Honorary Professor of the Humboldt University in Berlin.
Prior to her current appointments and until 2017, Emmanuelle Charpentier was Associate Professor at the Laboratory for Molecular Infection Medicine Sweden (MIMS, within the Nordic EMBL Partnership for Molecular Medicine) and visiting Professor at the Umeå Centre for Microbial Research (UCMR), Umeå University, where she habilitated in Medical Microbiology in 2013.
She was also Alexander von Humboldt Professor and Head of Department at the Helmholtz Centre for Infection Research in Braunschweig and Professor at the Hannover Medical School in Germany.
Emmanuelle Charpentier studied biochemistry, genetics and microbiology at the University Pierre and Marie Curie (Now Sorbonne University) in Paris, where she received her PhD in microbiology for her research performed at the Pasteur Institute.
Following her studies in France, she spent more than five years working in the US, where she held research associate positions in New York at the Rockefeller University, Skirball Institute of Biomolecular Medicine and New York University Langone Medical Center, and in Memphis, Tennessee, at the St Jude Children’s Research Hospital.
In 2002, she returned to Europe to lead her first independent research group as a Guest, Assistant and Associate Professor at the Max F. Perutz Laboratories (now Max Perutz Labs), University of Vienna in Austria, where she habilitated in microbiology in 2006.
In 2015, Emmanuelle Charpentier was awarded the Umeå University EC Jubilee Award that included the Excellence by Choice MIMS Postdoctoral Programme through a donation from the Kempe Foundations and the Knut and Alice Wallenberg Foundation.
She is also patron of the Excellence by Choice programme at MIMS.
At the 2017 Annual Celebration Ceremony, Emmanuelle was promoted as honorary doctor of medicine at Umeå University. She is a recipient of the Erik K. Fernström Prize and the Göran Gustafsson Prize. In 2019, she received the Scheele Award, which is awarded biannually by the Swedish Pharmaceutical Society.